European shares flat as tech losses counter healthcare boost
European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's ...
Correction to Novo Nordisk Flash Headline
Novo Nordisk guided for operating profit growth this year of 19% to 27% in constant exchange rates. The flash headline "Novo Nordisk Sees 2025 Op Profit Growth Of 19%-24% In Constant Exchange Rates," ...
The Financial Express28m
Novo Nordisk to seek regulatory approval for obesity drug early 2026
The company predicted operating profit for 2025 to climb between 19% and 27%, compared to growth of 26% last year.
Novo Nordisk shares gain 4.5% on fourth-quarter profit beat, Wegovy sales jump
Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...
Sensex, Nifty trade sideways; European mrkt decline
Despite trade tensions, US markets rebounded on Tuesday, recovering from steep losses on Monday. The S&P 500 climbed 0.7%, the NASDAQ Composite jumped 1.4%, and the Dow Jones Industrial Average edged ...
Novo Nordisk Expects Slowing Sales Growth This Year — Update
Novo Nordisk expects sales growth to slow this year as capacity constraints, intensifying competition and pricing pressure drag on sales of its blockbuster weight-loss and diabetes drugs. The Danish ...
City snapshot: Obesity drug Wegovy up 50% plus fruit and veg sales soar
Its a healthy morning as Novo Nordisk says sales of its obesity drug, Wegovy, rose 57% last year while Brits are buying more ...